EX-1
from 8-K
1 page
January10, 2023 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We Have Read the Statements Made by MusclePharm Corporation Included Under Item 4.01 of Its Current Report on Form 8-K Dated January4, 2023, to Be Filed With the Securities and Exchange Commission. We Agree With the Statements Concerning Our Firm Contained Therein. Sincerely, Moss Adams Llp
12/34/56